Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab von Meredith, Ruby F, Torgue, Julien J, Rozgaja, Tania A, Banaga, Eileen P, Bunch, Patty W, Alvarez, Ronald D, Straughn, Jr, J Michael, Dobelbower, Michael C, Lowy, Andrew M

Volltext